Filing Details
Raphael Pharmaceutical Inc. (OTC:RAPH) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedOTC:RAPH
Raphael Pharmaceutical Inc. (RAPH) Reports Material Event to SEC
Filing Details Raphael Pharmaceutical Inc. (OTC:RAPH) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context…
Market Context
Raphael Pharmaceutical Inc.'s stock currently trades at $1.40 with a market capitalization of $27.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Raphael Pharmaceutical Inc.'s stock.
All SEC filings for Raphael Pharmaceutical Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RAPH Stock Page
Frequently Asked Questions
Where can I read RAPH's SEC filings?
Browse all filings on our RAPH SEC filings page.
What types of SEC filings does Raphael Pharmaceutical Inc. file?
Public companies like Raphael Pharmaceutical Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.